Clinical Trial Update: Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

View source ↗

Summary

A University of Wisconsin–Madison trial is investigating the cognitive impact of neoadjuvant chemotherapy in patients with ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Ovarian Cancer, Cognitive Change | Status: RECRUITING